Adenosine Deaminase deficiency / Severe combined immunodeficiency
Definition
Biallelic pathogenic variants in the ADA gene disable the adenosine deaminase enzyme, which functions in purine metabolism; the toxic accumulation of deoxyadenosine metabolites within lymphocytes impairs the development of T, B and NK cells. A typical early-onset form diagnosed in infancy, ADA-SCID (~80%), and a milder late-onset form (ADA-CID, 15-20%) have been described; it accounts for approximately 15% of all SCID cases.
Gene/region examined
ADA - Exon 2, ADA - Exon 3, ADA - Exon 4, ADA - Exon 5, ADA - Exon 6, ADA - Exon 7, ADA - Exon 8, ADA - Exon 9, ADA - Exon 10
Method
Sequence analysis
Accepted sample types
EDTA blood, AF, CVS
Inheritance
Hereditary, autosomal recessive (AR).